Stratos Wealth Partners LTD. Increases Stock Holdings in Stryker Co. (NYSE:SYK)

Stratos Wealth Partners LTD. raised its holdings in Stryker Co. (NYSE:SYK) by 5.3% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 17,137 shares of the medical technology company’s stock after buying an additional 859 shares during the quarter. Stratos Wealth Partners LTD.’s holdings in Stryker were worth $6,170,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in the business. Dunhill Financial LLC grew its position in Stryker by 94.9% during the 3rd quarter. Dunhill Financial LLC now owns 76 shares of the medical technology company’s stock worth $27,000 after purchasing an additional 37 shares during the last quarter. Darwin Wealth Management LLC acquired a new stake in shares of Stryker during the third quarter worth $36,000. Crews Bank & Trust purchased a new stake in shares of Stryker during the fourth quarter valued at $39,000. Hara Capital LLC purchased a new position in Stryker in the 3rd quarter worth $42,000. Finally, Grove Bank & Trust lifted its position in Stryker by 84.8% during the 3rd quarter. Grove Bank & Trust now owns 122 shares of the medical technology company’s stock worth $44,000 after acquiring an additional 56 shares during the period. Institutional investors and hedge funds own 77.09% of the company’s stock.

Insider Buying and Selling at Stryker

In other news, Director Ronda E. Stryker sold 201,392 shares of the business’s stock in a transaction that occurred on Friday, January 31st. The stock was sold at an average price of $392.24, for a total transaction of $78,993,998.08. Following the transaction, the director now directly owns 3,642,075 shares in the company, valued at $1,428,567,498. The trade was a 5.24 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 5.50% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

SYK has been the topic of a number of research reports. Morgan Stanley raised Stryker from an “equal weight” rating to an “overweight” rating and increased their price objective for the company from $370.00 to $445.00 in a report on Monday, December 2nd. StockNews.com cut shares of Stryker from a “buy” rating to a “hold” rating in a research note on Thursday, January 30th. Stifel Nicolaus upped their price objective on shares of Stryker from $400.00 to $440.00 and gave the company a “buy” rating in a report on Wednesday, January 29th. Citigroup raised their target price on shares of Stryker from $411.00 to $450.00 and gave the stock a “buy” rating in a report on Wednesday, December 11th. Finally, BTIG Research upped their price target on shares of Stryker from $383.00 to $394.00 and gave the company a “buy” rating in a report on Wednesday, October 30th. Five investment analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $419.37.

Stryker Stock Performance

SYK opened at $399.01 on Thursday. The company has a market cap of $152.11 billion, a price-to-earnings ratio of 51.42, a PEG ratio of 2.78 and a beta of 0.96. The firm’s fifty day simple moving average is $376.87 and its two-hundred day simple moving average is $364.00. The company has a quick ratio of 1.32, a current ratio of 1.95 and a debt-to-equity ratio of 0.59. Stryker Co. has a 52-week low of $314.93 and a 52-week high of $406.19.

Stryker (NYSE:SYK) last posted its quarterly earnings data on Tuesday, January 28th. The medical technology company reported $4.01 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.87 by $0.14. Stryker had a return on equity of 23.58% and a net margin of 13.25%. During the same period in the previous year, the business posted $3.46 EPS. Equities analysts anticipate that Stryker Co. will post 13.5 earnings per share for the current fiscal year.

Stryker Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 30th. Investors of record on Monday, March 31st will be paid a $0.84 dividend. This represents a $3.36 annualized dividend and a yield of 0.84%. Stryker’s dividend payout ratio is currently 43.30%.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.